2004Journal of OncologyRequires access

An Analysis of Oxaliplatin Combined with Fluorouracil and Leucovorin in 40 Cases with Advanced Gastric Cancer

Yan Sun

Open publisher page 0 citations

Abstract

To evaluate the short-term efficacy and side effect of oxaliplatin combined with fluo-rouracil(5-Fu)and leucovorin(CF)in advanced gastric cancer.Forty cases with advanced gas-tric cancer were received oxaliplatin130mg/m 2 (2hours intravenous infusion in the first day)and CF200mg/m 2 followed by5-Fu500mg/m 2 (30minutes infusion)then5-Fu2.0g/m 2 (48hours continuous in-fusion)every three weeks.The efficacy were analyzed after two therapeutic cycles completed.The overall response rate was45.0%(CR,2cases;PR,16cases).Peripheral neuropathy was the main side effect(75%).[Conclusion]The oxaliplatin/5-Fu/CF regimen shows good efficacy with mild toxicity in treatment advanced gastric cancer.

About this research paper

What this paper is about

To evaluate the short-term efficacy and side effect of oxaliplatin combined with fluo-rouracil(5-Fu)and leucovorin(CF)in advanced gastric cancer.Forty cases with advanced gas-tric cancer were received oxaliplatin130mg/m 2 (2hours intravenous infusion in the first day)and CF200mg/m 2 followed by5-Fu500mg/m 2 (30minutes infusion)then5-Fu2.0g/m 2 (48hours continuous in-fusion)every three weeks.The efficacy were analyzed after two therapeutic cycles completed.The overall response rate was45.0%(CR,2cases;PR,16cases).Peripheral neuropathy was the main side effect(75%).[Conclusion]The oxaliplatin/5-Fu/CF regimen shows good efficacy with mild toxicity in treatment advanced gastric cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To evaluate the short-term efficacy and side effect of oxaliplatin combined with fluo-rouracil(5-Fu)and leucovorin(CF)in advanced gastric cancer.Forty cases with advanced gas-tric cancer were received oxaliplatin130mg/m 2 (2hours intravenous infusion in the first day)and CF200mg/m 2 followed by5-Fu500mg/m 2 (30minutes infusion)then5-Fu2.0g/m 2 (48hours continuous in-fusion)every three weeks.The efficacy were analyzed after two therapeutic cycles completed.The overall response rate was45.0%(CR,2cases;PR,16cases).Peripheral neuropathy was the main side effect(75%).[Conclusion]The oxaliplatin/5-Fu/CF regimen shows good efficacy with mild toxicity in treatment advanced gastric cancer.

Key concepts: Oxaliplatin, Medicine, Regimen, Fluorouracil, Cancer, Toxicity, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
An Analysis of Oxaliplatin Combined with Fluorouracil and Leucovorin in 40 Cases with Advanced Gastric Cancer — Research Paper | ScholarLens